Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
PLoS One ; 11(3): e0149830, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-26934472

RESUMO

BACKGROUND: EspP (E. coli secreted serine protease, large plasmid encoded) is an extracellular serine protease produced by enterohemorrhagic E. coli (EHEC) O157:H7, a causative agent of diarrhea-associated Hemolytic Uremic Syndrome (D+HUS). The mechanism by which EHEC induces D+HUS has not been fully elucidated. OBJECTIVES: We investigated the effects of EspP on clot formation and lysis in human blood. METHODS: Human whole blood and plasma were incubated with EspP(WT )at various concentrations and sampled at various time points. Thrombin time (TT), prothrombin time (PT), and activated partial thromboplastin time (aPTT), coagulation factor activities, and thrombelastgraphy (TEG) were measured. RESULTS AND CONCLUSIONS: Human whole blood or plasma incubated with EspP(WT) was found to have prolonged PT, aPTT, and TT. Furthermore, human whole blood or plasma incubated with EspP(WT) had reduced activities of coagulation factors V, VII, VIII, and XII, as well as prothrombin. EspP did not alter the activities of coagulation factors IX, X, or XI. When analyzed by whole blood TEG, EspP decreased the maximum amplitude of the clot, and increased the clot lysis. Our results indicate that EspP alters hemostasis in vitro by decreasing the activities of coagulation factors V, VII, VIII, and XII, and of prothrombin, by reducing the clot strength and accelerating fibrinolysis, and provide further evidence of a functional role for this protease in the virulence of EHEC and the development of D+HUS.


Assuntos
Fatores de Coagulação Sanguínea/metabolismo , Coagulação Sanguínea/fisiologia , Escherichia coli Êntero-Hemorrágica/metabolismo , Proteínas de Escherichia coli/metabolismo , Serina Endopeptidases/metabolismo , Serina Proteases/metabolismo , Transtornos da Coagulação Sanguínea/metabolismo , Escherichia coli O157/metabolismo , Tempo de Lise do Coágulo de Fibrina/métodos , Fibrinólise/fisiologia , Síndrome Hemolítico-Urêmica/metabolismo , Humanos , Tempo de Tromboplastina Parcial/métodos , Protrombina/metabolismo , Tempo de Protrombina/métodos , Trombose/metabolismo
3.
Am J Hematol ; 82(5): 405-8, 2007 May.
Artigo em Inglês | MEDLINE | ID: mdl-17133422

RESUMO

Chronic myelomonocytic leukemia (CMML) is an uncommon disorder characterized by monocytosis of the peripheral blood, absence of the Philadelphia chromosome, fewer than 20% blasts, and one or more lineages showing dysplastic features. Splenomegaly is frequently seen and may be massive. A 56-year-old man with stable CMML and moderate splenomegaly presented to the emergency department with generalized abdominal pain and abrupt drop in hemoglobin. Abdominal imaging revealed splenic rupture and emergency splenectomy was undertaken, with complete recovery. Atraumatic rupture of the spleen has rarely been reported as a complication of CMML or other myelodysplastic disorders. This report should alert physicians to consider this diagnosis in patients with CMML and acute abdominal pain.


Assuntos
Abdome Agudo/etiologia , Leucemia Mielomonocítica Crônica/complicações , Ruptura Esplênica/etiologia , Emergências , Hemoperitônio/etiologia , Humanos , Infiltração Leucêmica , Masculino , Pessoa de Meia-Idade , Ruptura Espontânea , Baço/patologia , Esplenectomia , Ruptura Esplênica/diagnóstico , Ruptura Esplênica/cirurgia , Esplenomegalia/etiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...